Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06803589 · ClinicalTrials.gov registry record · Early Phase 1

Growth Hormone for the Treatment of Gastroparesis

A Early Phase 1 study of Gastroparesis, sponsored by Mayo Clinic.

Recruiting
Registry status
Early Phase 1
Development phase
10
Enrollment target
2
Study locations

NCT06803589: Recruiting Early Phase 1 study of Gastroparesis, sponsored by Mayo Clinic.

NCT06803589 is a Early Phase 1 study of Gastroparesis that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 10 participants, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06803589, a Early Phase 1 study of Gastroparesis, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
Early Phase 1
Development phase
10 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine whether treatment with Growth Hormone results in symptomatic improvement in patients with gastroparesis.

Conditions Studied

Gastroparesis

Interventions

  • DRUG Growth Hormone

Study Locations (2)

Arizona

  • Mayo Clinic - Phoenix
  • Mayo Clinic in Arizona - Scottsdale

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2024-10-22
Est. Completion 2027-12
Phase Early Phase 1

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06803589

The ClinicalTrials.gov registry entry for NCT06803589 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (97% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gastroparesis appearing as the primary indexed condition, and to 1 intervention - of which Growth Hormone is the first listed.

NCT06803589 reports 2 study locations spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT06803589 about?

NCT06803589 is a clinical study titled "Growth Hormone for the Treatment of Gastroparesis". The purpose of this study is to determine whether treatment with Growth Hormone results in symptomatic improvement in patients with gastroparesis.

What is the current status of trial NCT06803589?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2024-10-22. Estimated completion is 2027-12.

What conditions does trial NCT06803589 study?

This clinical trial studies the following conditions: Gastroparesis.

What interventions are being tested in trial NCT06803589?

The interventions under investigation include: Growth Hormone (DRUG).

Who is sponsoring clinical trial NCT06803589?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06803589 being conducted?

This trial has 2 study locations across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Gastroparesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Gastroparesis

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.